leisure time -WSS

leisure time

author：Wikipedia 2025-09-29 18:15:50 - browse：442

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Cassava reveals details — and problems — with Alzheimer's study

focus

WSS

As biotech industry slumps, bioscience job market is upside down

Maker of FluMist seeks to allow at

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

The FDA weighs the risks of candy

Flagship Pioneering launches a new biotech in two countries

CDC director unscathed in first congressional testimony

focus

leisure time

knowledge

Cancer drug shortages should be causing more outrage

30 years of 'Listening to Prozac'

Bright Health sells Medicare Advantage business to Molina

Rep. Raul Ruiz on the physician shortage and more

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Meta's Zuckerberg and Chan on track to put $50 billion into science

Walensky prepares to leave CDC — and Congress — behind

Senate panel to vote on hospitals, PBMs, prisoner care

Drug repurposing or repositioning? The language matters

Medtronic CEO on promising devices for diabetes, hypertension

hotspot

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: XBI biotech index, Akero Therapeutics

Eli Lilly to pay $200M for Beam’s stake in gene

What don’t we know about an Alzheimer’s drug side effect?

Emergency medicine has repudiated 'excited delirium.' Now what?

WHO may add ‘noma' to its list of neglected tropical diseases

knowledge

leisure time

focus

focus